$9.87
-1.33-11.87%
At close: -
$9.87
0.000.00%
After Hours: Jan 10, 4:00 PM EDT
Comments
Loading...
Mineralys Therapeutics (MLYS) Forecast
NewsEarningsMineralys Therapeutics (MLYS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestMineralys Therapeutics (NASDAQ:MLYS) Stock Quotes, Forecast and News Summary
Mineralys Therapeutics Stock (NASDAQ: MLYS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Mineralys Therapeutics (MLYS) stock?
You can purchase shares of Mineralys Therapeutics (NASDAQ:MLYS) through any online brokerage.
Who are Mineralys Therapeutics (MLYS) competitors?
Other companies in Mineralys Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Upstream Bio (NASDAQ:UPB), Replimune Group (NASDAQ:REPL), Prothena Corp (NASDAQ:PRTA) and Pharming (NASDAQ:PHAR).
What is the forecast, or price target, for Mineralys Therapeutics (MLYS) stock?
Mineralys Therapeutics has a consensus price target of $34.29.
What is the current price for Mineralys Therapeutics (MLYS)?
The stock price for Mineralys Therapeutics (NASDAQ: MLYS) is $9.87 last updated January 10, 2025 at 4:00 PM EST.
Does Mineralys Therapeutics (MLYS) pay a dividend?
There are no upcoming dividends for Mineralys Therapeutics.
When is Mineralys Therapeutics (NASDAQ:MLYS) reporting earnings?
Mineralys Therapeutics’s Q4 earnings are confirmed for Thursday, March 20, 2025.
Is Mineralys Therapeutics (MLYS) going to split?
There is no upcoming split for Mineralys Therapeutics.
What sector and industry does Mineralys Therapeutics (MLYS) operate in?
Mineralys Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.